Bernstein Sticks to Their Hold Rating for Agilon Health (AGL)
TipRanks (Wed, 27-May 7:01 AM ET)
agilon health Reports First Quarter 2026 Results
Business Wire (Wed, 6-May 4:05 PM ET)
agilon health Appoints Tim O'Rourke as Chief Executive Officer
Business Wire (Mon, 27-Apr 4:15 PM ET)
Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Thu, 9-Apr 7:58 PM ET)
agilon health Sets Date to Report First Quarter 2026 Financial Results
Business Wire (Mon, 6-Apr 4:05 PM ET)
Globe Newswire (Tue, 31-Mar 8:15 AM ET)
agilon health Announces Reverse Stock Split
Business Wire (Wed, 18-Mar 4:05 PM ET)
Kuehn Law Encourages Investors of Agilon Health, Inc. to Contact Law Firm
PRNewswire (Thu, 5-Mar 1:12 PM ET)
Globe Newswire (Mon, 2-Mar 4:00 PM ET)
Globe Newswire (Mon, 2-Mar 12:33 PM ET)
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
Agilon Health trades on the NYSE stock market under the symbol AGL.
As of May 29, 2026, AGL stock price climbed to $92.97 with 100,678 million shares trading.
AGL has a beta of 5.88, meaning it tends to be more sensitive to market movements. AGL has a correlation of 0.17 to the broad based SPY ETF.
AGL has a market cap of $1.55 billion. This is considered a Small Cap stock.
Last quarter Agilon Health reported $1 billion in Revenue and $1.80 earnings per share. This beat revenue expectation by $41 million and exceeded earnings estimates by $.85.
In the last 3 years, AGL traded as high as $538.00 and as low as $7.48.
The top ETF exchange traded funds that AGL belongs to (by Net Assets): IWM, FNDA, VTI, IWO, ISMD.
AGL has outperformed the market in the last year with a price return of +58.2% while the SPY ETF gained +29.9%. AGL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +531.1% and +18.4%, respectively, while the SPY returned +10.5% and +1.1%, respectively.
AGL support price is $82.96 and resistance is $97.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGL shares will trade within this expected range on the day.